drugset / Trial / NCT01982318
A Prospective Randomized, Double-Blind, Placebo-Controlled Trial Comparing VitroGro® ECM to Placebo in Patients With Venous Leg Ulcers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to assess the efficacy and safety of VitroGro® combined with standard care in the treatment of Venous Leg Ulcers (VLUs) compared to Placebo with standard care over the course of the 8-week treatment phase.
Timeline
- Start
- 2017-01
- Primary completion
- 2018-06
- Completion
- 2019-06
Outcome
Outcome not reported
Stopped: “Study discontinued. Superseded by NCT02973893 VF00102.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VitroGro® ECM | Protein / enzyme biologic | — | Topical |